Market Size
End-Stage Renal Disease
The number of ESRD patients in China is among the top, but the rate of hemodialysis treatment is lower than the global average.
Kidney Disease in China
The number of ESRD patients in China is among the top, but the rate of hemodialysis treatment is lower than the global average.
Estimate in Market
The number of ESRD patients in China is among the top, but the rate of hemodialysis treatment is lower than the global average.
Potential Forecast in Market
The number of ESRD patients in China is among the top, but the rate of hemodialysis treatment is lower than the global average.
There are more than 2 million ESRD end-stage renal disease patients in China:
At the same time, as a country with a large population in the world, China is gradually entering the aging stage; glomerulitis, diabetic nephropathy and hypertensive nephropathy are the top three causes of dialysis.
The number of ESRD patients in China is in the forefront, but the rate of hemodialysis treatment is lower than the global average; the vast majority of patients will not receive treatment and the number of patients will continue to increase in the future, the demand for dialysis treatment is huge.
